BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

Free Newsletters
My Subscriptions

News by Subject
News by Disease
News by Date
Search News
Post Your News

Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Pharm Country
  Bio NC
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™


Company Profiles

Research Store

Research Events
Post an Event
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile


Pfizer Inc. 

Pfizer Research Technology Center (RTC)
620 Memorial Drive
Cambridge  Massachusetts  02139  U.S.A.
Phone: 617-551-3000 Fax: 617-551-3111


The Pfizer Research Technology Center (RTC) in Cambridge, MA houses cutting edge research groups focused on RNAi therapeutics, Systems Biology and Biological Profiling, Regenerative Medicine and Computational Sciences.

Headquartered at the RTC, and comprising research groups in Cambridge and Düsseldorf, the goal of Pfizer RNAi Therapeutics is clear - delivering RNAi therapies to meet our patient needs and in doing so helping Pfizer become a top tier biotherapeutics company.

Pfizer Regenerative Medicine is collaborating with local experts to develop Stem Cell Therapies to treat diseases.

The Systems Biology, Biological Profiling and Computational Sciences groups are using their niche skills and expertise to focus on increasing the effectiveness of the research process through better target selection, reduced attrition and the ability to manipulate and manage data to support the research process.

Without the constraints of a therapeutic area portfolio, RTC colleagues are free to apply cutting-edge techniques and technologies with broad utility across different therapeutic areas.

The RTC is located in one of the richest scientific environments in the world, surrounded by more than 300 biotechnology companies and thousands of scientific innovators in world-leading research hospitals and academic institutions. A key element in the success of the RTC is the growing and dynamic portfolio of partnerships with these innovators, focused on addressing the strategic needs of the site and of Pfizer's research division.

The RTC aims to balance the strength of Pfizer R&D with the nimble feel of a small biotech, and creates an exciting and team-based scientific environment for 150 colleagues, with a wide range of scientific skills and experience. The working environment emphasizes collaboration and cooperation with most scientific questions solved through the work of a cross-disciplinary team. The unique working environment - truly a small biotech with the backing of the largest research budget in the industry - supports the unique science of the site.

For more information, please visit

 Key Statistics

Ownership: Public

Web Site: Pfizer Research Technology Center (RTC)
Symbol: PFE

 Company News
Pharma Companies Are Framing Retention Plans 8/21/2007 7:36:46 AM
BioSpace, Inc. And Massachusetts Biotechnology Council, Inc. Unveil 2006 Genetown™ Campaign 12/14/2005 6:22:26 PM
BioSpace Celebrates A Decade Of Genetown™10/19/2005 5:12:28 PM
Drug Companies Launch New Discount Card10/19/2005 5:12:12 PM
Three New Pfizer Inc. (PFE) Studies Show A Single Dose Of Azithromycin Microspheres Is As Effective As Multi-Dose Treatment For Respiratory Tract Infections In Adults 10/19/2005 5:12:02 PM
Pulmonary Hypertension Association Release: Viagra Study Spotlights Pulmonary Hypertension 10/19/2005 5:12:02 PM
Eyetech Pharmaceuticals, Inc. (EYET) To Present 2-year Data For Macugen(TM) (Pegaptanib Sodium Injection) At The Retina Subspecialty Symposium At the American Academy of Ophthalmology Meeting 10/19/2005 5:11:51 PM
Pfizer Inc. (PFE) Invites Public To Listen To Webcast Of October 20 Conference Call With Analysts 10/19/2005 5:11:50 PM